Intuitive Surgical Inc. (ISRG) has been garnering positive attention recently from various market players. Finance analyst Jim Cramer has spoken highly of the group, despite fluctuations in the market. For Q2, the company has reported robust earnings, with revenues surpassing $2.44 billion due to increasing demand for robotic surgery. Despite market concerns over tariffs and profits, various financial institutions and brokers maintain a bullish stance on the bio-tech giant, maintaining 'Buy' ratings and increasing price targets. The FDA has approved the company's new vessel sealer tool, further endorsing its pivotal role in the industry. The company has also seen some criticism over risks to margin amidst these triumphs. Their expanded presence in the European Market and successful entries in transatlantic telesurgery leave bright prospects for the future.
Intuitive Surgical ISRG News Analytics from Sun, 04 May 2025 07:00:00 GMT to Sat, 26 Jul 2025 23:11:30 GMT -
Rating 8
- Innovation 7
- Rumor -5
